[ad_1] Has the National Agency for the Safety of Medicinal Products (ANSM) waited too long before granting Truvada anti-HIV prophylaxis for pre-exposure prophylaxis (PrEP) before premature badual intercourse, its marketing authorization? This …
Read More »